AboutStandards
GLOW research peptide vial — OSYRIS Health
AESTHETICS

GLOW

$89.99

GLOW is a proprietary multi-peptide research blend composed of GHK-Cu (50MG), BPC-157 (10MG), and TB-500 (10MG), formulated for synergistic in vitro and in vivo study of cellular signaling, tissue regeneration, angiogenesis, and peptide-receptor interactions. This product is supplied as a lyophilized powder and is intended strictly for research purposes only.

QuantityStandard research vial
PuritySee COA
Free shipping on orders over $200
Download Certificate of Analysis
About This Compound

Product Overview

GLOW is an OSYRIS Health aesthetics stack combining three compounds: BPC-157, GHK-Cu, and TB500. Each component is individually studied in skin biology and tissue remodeling research, and the stack combines them for protocols investigating multi-mechanism approaches to skin and tissue regeneration.

BPC-157 contributes growth factor modulation (EGF, VEGF, FGF upregulation). GHK-Cu contributes copper-dependent collagen synthesis and gene expression modulation (affecting 4,000+ genes in fibroblast studies). TB500 contributes actin-mediated cell migration. Together, they represent three distinct approaches to tissue biology — growth factor signaling, gene expression regulation with copper delivery, and cytoskeletal dynamics.

GLOW stack multi-pathway skin regeneration research visualization — OSYRIS Health
Research Applications

Mechanism and Experimental Context

The GLOW stack allows researchers to investigate whether activating three different tissue remodeling pathways simultaneously produces effects beyond any single compound. BPC-157's growth factor upregulation, GHK-Cu's collagen synthesis and gene expression effects, and TB500's cell migration promotion represent complementary mechanisms that do not compete for the same receptors or pathways.1

All three components have been individually studied for ECM effects. GHK-Cu promotes collagen I and III synthesis while modulating metalloproteinase activity. BPC-157 promotes tissue remodeling through VEGF-mediated angiogenesis. TB500 promotes the cell migration required to populate repair sites. The combination is studied in models examining comprehensive ECM regeneration.2

Like the BPC/TB500 Blend, GLOW enables direct comparison between multi-compound and single-compound protocols — but with a third variable (copper peptide biology) that adds the dimension of gene expression modulation and copper-dependent enzyme activity.

Referenced Studies

Source Literature

[1]

Pickart L, et al. "The human tri-peptide GHK and tissue remodeling." Journal of Biomaterials Science, 2008. PubMed: PMID 18611233

[2]

Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design, 2011. PubMed: PMID 21861804

Certificate of Analysis

Batch Documentation

Current published batch documentation is surfaced on-page whenever the provider exposes a public COA asset.

GLOW certificate of analysis

Frequently Asked Questions

Questions About GLOW

GLOW combines BPC-157, GHK-Cu, and TB500 in a single vial for multi-compound skin and tissue biology research.

BPC-157 modulates growth factors (EGF, VEGF, FGF). GHK-Cu promotes collagen synthesis and modulates gene expression. TB500 drives actin-mediated cell migration. They work through three different mechanisms.

The compounds are the same, but the blend offers them pre-combined for protocols that require all three. Buying individually gives flexibility in ratios and separate testing.

All three components have research applications in skin biology: collagen synthesis (GHK-Cu), wound healing (BPC-157), and tissue remodeling (TB500). The combination targets multiple layers of skin and tissue regeneration.

GLOW focuses on aesthetics — BPC-157 + GHK-Cu + TB500. KLOW focuses on immune/recovery — KPV + BPC-157 + TB500 + GHK-Cu. KLOW adds KPV (anti-inflammatory) and is categorized under Immune & Host Defense.

Store lyophilized at 2-8°C for short-term or -20°C for long-term. Protect from light.

Each component is independently tested via HPLC and LC-MS. COA downloadable on this page.

The GLOW stack contains three compounds. Adding additional compounds to a protocol is a research design decision. Consult the individual product pages for each component's specifications.

Every Batch Tested by an Independent Lab

We publish the Certificate of Analysis for every product. See our full testing process.

See Our Standards →

All products sold by OSYRIS Health are intended for laboratory research purposes only and are not for human or veterinary use. The information provided on this page describes published scientific research and does not constitute medical advice, diagnosis guidance, or a recommendation for any specific use. Always ensure compliance with local regulations.